University of Nebraska - Lincoln

DigitalCommons@University of Nebraska - Lincoln
Papers in Veterinary and Biomedical Science

Veterinary and Biomedical Sciences, Department of

2002

Mechanisms Counteracting Swelling in Brain Cells
During Hyponatremia
Herminia Pasantes-Morales
Universidad Nacional Autónoma de México, hpasante@ifisiol.unam.mx

Rodrigo Franco
Universidad Nacional Autónoma de México, rfrancocruz2@unl.edu

Benito Ordaz
Universidad Nacional Autónoma de México

Lenin D. Ochoa
Universidad Nacional Autónoma de México

Follow this and additional works at: http://digitalcommons.unl.edu/vetscipapers
Part of the Biochemistry, Biophysics, and Structural Biology Commons, Cell and Developmental
Biology Commons, Immunology and Infectious Disease Commons, Medical Sciences Commons,
Veterinary Microbiology and Immunobiology Commons, and the Veterinary Pathology and
Pathobiology Commons
Pasantes-Morales, Herminia; Franco, Rodrigo; Ordaz, Benito; and Ochoa, Lenin D., "Mechanisms Counteracting Swelling in Brain
Cells During Hyponatremia" (2002). Papers in Veterinary and Biomedical Science. 178.
http://digitalcommons.unl.edu/vetscipapers/178

This Article is brought to you for free and open access by the Veterinary and Biomedical Sciences, Department of at DigitalCommons@University of
Nebraska - Lincoln. It has been accepted for inclusion in Papers in Veterinary and Biomedical Science by an authorized administrator of
DigitalCommons@University of Nebraska - Lincoln.

Published as Review Article in Archives of Medical Research 33 (2002), pp. 237–244; doi: 10.1016/S01884409(02)00353-3
Copyright © 2002 IMSS (Instituto Mexicano del Seguro Social). Published by Elsevier Science Inc.
Used by permission.
Submitted June 21, 2001; accepted November 7, 2001.

Mechanisms Counteracting Swelling in
Brain Cells During Hyponatremia
Herminia Pasantes-Morales, Rodrigo Franco, Benito Ordaz
and Lenin D. Ochoa
Departamento de Biofísica, Instituto de Fisiología Celular, Universidad Nacional Autónoma de
México (UNAM), Mexico City, Mexico
Corresponding author – Herminia Pasantes-Morales, Ph.D., email hpasante@ifisiol.unam.mx

Abstract
Water gain in the brain consequent to hyponatremia is counteracted by mechanisms that initially
include a compensatory displacement of liquid from the interstitial space to cerebrospinal fluid and
systemic circulation and subsequently an active reduction in cell water accomplished by extrusion
of intracellular osmolytes to reach osmotic equilibrium. Potassium (K+), chloride (Cl–), amino acids,
polyalcohols, and methylamines all contribute to volume regulation, with a major contribution of
ions at the early phase and of organic osmolytes at the late phase of the regulatory process. Experimental models in vitro show that osmolyte fluxes occur via leak pathways for organic osmolytes and
separate channels for Cl– and K+. Osmotransduction signaling cascades for Cl– and taurine efflux
pathways involve tyrosine kinases and phosphoinositide kinases, while Ca2+ and serine-threonine
kinases modulate K+ pathways. In-depth knowledge of the cellular and molecular adaptive mechanisms of brain cells during hyponatremia contributes to a better understanding of the associated
complications, including the risks of inappropriate correction of the hyponatremic condition.
Keywords: volume regulation, taurine, hyposmolarity, regulatory volume decrease
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Introduction
The ability to regulate cell volume is an ancient conserved trait present in essentially all
species throughout evolution. Maintenance of constant cell volume is a homeostatic imperative in animal cells. Changes in cell water content by affecting the concentration of
messenger molecules impair the complex signaling network crucial for cell functioning
and intercellular communication. Although under physiologic conditions extracellular fluids have a highly controlled osmolarity, a variety of diseases is paralleled by alterations of
systemic osmolarity. In addition, the intracellular volume constancy is continuously compromised by the generation of local and transient osmotic microgradients associated with
uptake of nutrients, secretion, cytoskeletal remodeling, and transynaptic ionic gradients.
Cell volume disturbances have particularly dramatic consequences in the brain. The
limits to expansion imposed by the rigid skull give narrow margins for buffering of intracranial volume changes. As expansion occurs, constraining of small vessels generates episodes of anoxia ischemia, infarct, excitotoxicity, and neuronal death. Under extreme
conditions, caudal herniation of the brain parenchyma through the foramen magnum affects brain stem nuclei, resulting in death by respiratory and cardiac arrest (1).
Hyponatremia is the most common cause of hyposmotic swelling in brain cells. This
condition results from an imbalance between intake and excretion of water and electrolytes
derived from either an excess of water or a sodium (Na+) deficit. Water excess may derive
from excessive oral intake as in psychotic polydipsia, or more commonly from impaired
renal elimination as a consequence of inappropriate secretion of antidiuretic hormone, glucocorticoid deficiency, hypothyroidism, use of thiazide diuretics, and renal or hepatic failure. A variety of diseases or conditions such as head trauma, brain tumor, and cerebrovascular accidents result in hyponatremia associated with the syndrome of inappropriate
secretion of antidiuretic hormone (SIADH) or the cerebral salt-wasting syndrome (CSWS).
Both syndromes have marked similarities with regard to clinical context and presentation,
with euvolemia in SIADH and hypovolemia in CSWS the most clear contrasting variables.
CSWS is characterized by excessive renal sodium loss (eventually in relation to a natriuretic factor) resulting in volume depletion and hyponatremia (2). Na+ loss also results from
mineralocorticoid deficiency, nephrotic syndrome, osmotic diuresis, vomiting, or diarrhea.
Hyponatremia may also be caused by rapid correction of uremia by excessive hemodialysis and by infusion of hypotonic solutions in the perioperative period. Hyponatremia is a
common state in the elderly and during pregnancy (3–5). Fatal hyponatremia-induced cerebral edema has been recently associated with the use of the drug Ecstasy (6).
Adaptive Response of Brain Cells to Hyposmotic Conditions: Studies in Vivo
In the face of a decrease in external osmolarity, the brain does not exhibit the behavior
predicted for a perfect osmometer. During chronic hyponatremia, only approximately 40%
of the expected water gain occurs within the first hours; thereafter, total water content decreases progressively to nearly complete normalization (7). The first adaptive response is
a compensatory displacement of liquid from the interstitial space to the cerebrospinal
fluid; thereafter, the excess in cerebrospinal fluid enters the systemic circulation. The next
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adaptive brain reaction is the extrusion of intracellular solutes, mainly the inorganic ions
potassium (K+) and chloride (Cl–) and a number of small organic molecules, prominently
amino acids with osmotically obligated water. Some loss of Na+ is also observed in whole
brain studies, likely displaced from the extracellular space (8). Studies in animal models of
chronic hyponatremia have shown the greatest loss of Na+ and Cl– during the first 3 h,
while K+ loss is slower, achieving significance only after this first time period (8). From
early studies on this subject, it was evident that the decrease in electrolytes was not sufficient to compensate for the loss of water observed and that the involvement of other osmotically active solutes needed to be considered. These molecules, initially referred to as
idiogenic osmolytes, were further identified as organic molecules such as amino acids, polyalcohols, and methylamines, which were found to contribute significantly to the adaptive
brain response to hyponatremia (8). A decrease in the concentration of myo-inositol, phosphocreatine/creatine, glycerophosphoryl choline and of the most abundant amino acids
(glutamate, glutamine, taurine, and glycine) has been consistently observed in chronic hyponatremia (9,10). The contribution of organic osmolytes and electrolytes to the total brain
osmolarity change has been estimated as 23–29% and 62–70%, respectively (table 1). While
decreases of electrolytes reverse with time, decreases of organic osmolytes, particularly
taurine, are sustained as long as hyponatremic conditions persist (9).
Table 1. Electrolytes and organic osmolyte content in rat brain during chronic hyponatremia
Osmolyte (nmol/kg DBW)a

Hyponatremic
(nmol/kg DBW)

Normonatremic

Decrease

Electrolytes
Sodium

279

250

29

Potassium

480

424

56

Chloride

152

118

34

All electrolytes

911

792

192

Organic osmolytes
Glutamate

52.9

32.5

Glutamine

14.2

6.5

20.4
7.7

Taurine

13.8

2.1

11.7

GABA

1.7

0.9

0.8

Aspartate

2.2

1.7

0.5

N-acetylaspartate

7.5

5.9

1.6

5.3

10.7

Myo-inositol

16

Creatine

34.8

17.1

17.7

Phosphoethanolamine

1.2

0.8

0.4

GPCb

1.1

0.6

145.4

73.4

All organic osmolytes

0.5
72

a. DBW: dry brain weight. Recalculated from (8,9). Data are from rats after 2–3 days of hyponatremia.
b. GPC: glycerophosphorylcholine.

Taken together, these studies show that immediate response to hyponatremia in brain
is in charge of K+ and Cl– efflux, and that sustained adaptation is carried out by organic
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osmolytes, particularly taurine. This has been confirmed in studies in vitro in astrocytes
demonstrating how myo-inositol- and taurine swelling-activated efflux persists for several
hours after the hyposmotic stimulus, in contrast to glutamate and K+, which remained unchanged (11,12). These results highlight differences in handling the various osmolytes.
Loss of K+ and Cl– is an emergency mechanism to counteract brain swelling rapidly, but it
is potentially harmful on a long-term basis, in contrast to the relative innocuousness of
most organic osmolytes. Taurine in particular may be a perfect osmolyte because it is metabolically inert and exhibits only weak synaptic interaction (13).
Estimation of osmolyte change in all these studies does not discriminate among regional
variations within the brain or possible differences in cell type. Studies in vitro, in tissue
slices as well as in homogeneous cultured cells exposed to media of reduced osmolarity
(by decreasing NaCl concentration), represent a suitable initial approach to clarify these
questions and to obtain insight into the mechanisms of brain adaptation to hyponatremia.
In-depth knowledge of these mechanisms is important to determine the development of
symptoms in patients with hyponatremia and is critical for avoiding risks of inadequate
correction procedures.
Regulatory Volume Decrease: Cellular and Molecular Mechanisms
Studies in cells such as neurons as well as glial cells in culture have contributed enormously to our knowledge concerning the basic mechanisms of adaptive cell volume recovery after hyposmotic swelling. Cells are, in general, highly permeable to water; therefore,
any difference in osmolarity across the membrane results in net water movements in the
direction necessary to reach osmotic equilibrium. In the face of a decrease in external osmolarity, cells initially behave as nearly perfect osmometers and swell with a magnitude
proportional to the osmolarity reduction. Immediately after, an active volume correction
begins, based on the extrusion of intracellular solutes together with osmotically obligated
water; this tends to reduce osmotic difference and normalize cell volume. This adaptive
mechanism is known as regulatory volume decrease (RVD). The time necessary to fully
activate RVD and regain cell volume is variable in the different cell types. In brain cells in
vitro, RVD occurs rapidly, with a 70–80% recovery reached within a few minutes as a result
of osmolyte activation (fig. 1A).
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Figure 1. Regulatory volume decrease in cultured cerebellar granule neurons. A. Upon
exposure to media of reduced osmolarity (50%), cerebellar granule neurons exhibit a
rapid increase in cell volume followed by an active phase of volume regulation occurring
despite the persistence of the hyposmotic medium. Volume recovery is approximately
60% within 15 min. B. Volume recovery is accomplished by the efflux of inorganic and
organic osmolytes () 3H-taurine (), 125I (as tracer for Cl–), and (●) 86Rb (as tracer for K+).
Results are expressed as efflux rate constants, as described in the work of Sánchez-Olea et
al. (14,26).

RVD is a complex chain of events requiring a sensor to detect transient changes in cell
volume, a signaling cascade to transduce information on volume change into activation of
pathways for osmolyte extrusion, and a memory of the original cell volume that sets the
timing for inactivation of the regulatory process. During the past years, the majority of
efforts have been directed toward identifying and characterizing the osmolyte efflux pathways; thus, it is only recently that interest has been aroused in understanding osmotransduction mechanisms. There is at present only scarce information concerning the nature of
volume-sensing mechanisms.
RVD has been studied in detail in astrocytes and neurons from primary cultures (14,15),
in neuroblastoma (16), glioma cells lines (17), and in snail neurons (18). RVD has also been
found in freshly isolated cells from hippocampus (19). The situation is unclear in more
integrated preparations because in some of these preparations RVD has been undetectable
(20); nevertheless, the results in vivo previously described clearly indicate the occurrence
of compensatory mechanisms, although variations in ability to regulate volume may occur
within brain regions.
Pathways for Osmolyte Fluxes Activated during RVD
The osmolytes responsible for RVD are essentially the same in most cell types including
brain cells and are grouped into two broad categories: the most concentrated intracellular
ions (K+ and Cl–) and small organic molecules, prominently amino acids, polyalcohols, sugars, and methylamines. In most cells examined to date, osmolyte fluxes occur essentially
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by diffusive pathways, i.e., K+ and Cl– efflux through separate channels with marginal participation of electroneutral cotransporters, and organic osmolytes through leak pathways
with no contribution of energy-dependent carriers (21).
Osmosensitive Channels
Volume-sensitive K+ and Cl– fluxes in most cell types occur through separate channels that
may possess some interdependence but that clearly exhibited a different selectivity. Cl–
channels activated by hyposmotic swelling are typically outward rectifiers with an intermediate unitary conductance of 40–78 pS, inactivating at potentials of +60 mV and above.
These channels have been characterized in numerous cell types (22,23). In brain cells, the
volume-sensitive Cl– channel (VSCC) has been studied in astrocytes (24), C6 glioma cells
(25), and cerebellar granule neurons (26). The VSCC has high selectivity of anions over
cations but exhibits broad anion selectivity, being permeable to the majority of monovalent
anions and even to large anions such as gluconate and methansulfonate. Activation of
VSCC requires ATP but not its hydrolysis. Typical Cl– channel blockers such as DIDS, SITS,
9-AC, and DPC inhibit VSCC with different potencies according to cell type. Other agents
with inhibitory effects on the VSCC include NPPB, DDF, niflumic acid, and flufenamic
acid (23,24). Notably, arachidonic acid and other polyunsaturated fatty acids are potent
VSCC blockers (27,28). For details on the basic properties of VSCC, readers are referred to
recent reviews on this topic (22,23).
The molecular species of VSCC are as yet unidentified. Approximately eight members
of a family of voltage-gated Cl– channels have been cloned and characterized. Some are
activated by swelling (29), but none unequivocally corresponds to VSCC. Some evidence
appears to support the ClC3 channel gene as encoding the channel protein responsible for
the volume-sensitive Cl– current (30), but recent evidence argues against this channel being
indeed the VSCC (31). Some molecules with Cl– permeability properties, namely Icln and
the P-glycoprotein, are suggested to play a role in osmosensitive Cl transport either as a
Cl– pathway properly, a possibility recently questioned, or as regulating elements of the
functional Cl– channels (review in Reference 30). Not unlikely but at present undefined is
the question of whether different types of VSCC and other anion-permeating molecules
coincide in the same cell. An interesting avenue for future research may be the identification of the factors and situations that determine the functioning of one or another of these
different osmosensitive channels.
In contrast to the broad similarities found for VSCC in different types of cells, swelling
activates at least two different types of K+ channels. In some—mainly epithelial—cells,
volume-sensitive K+ channels (VSKC) are calcium (Ca2+)-dependent, large-conductance
(100–200 pS) channels. In other cell types, VSCK channels are small channels with conductances of 20–30 pS, the majority Ca2+-independent (review in Reference 32). While the first
group of channels has been clearly identified as high conductance K+ channels, the identity
of the second group is still unclear. Some types of voltage-gated K+ channels appear to
permeate K+ efflux during RVD in lymphocytes, and Kv channels are activated by hyposmolarity in hippocampal pyramidal neurons, although not all Kv subtypes are responsive (32).
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Volume-Sensitive Pathways for Organic Osmolytes
A number of organic osmolytes are released during hyposmotic swelling, but the details
of their efflux pathways are known for only a few. The best-characterized organic osmolytes are those for taurine and myo-inositol (33–35); additionally, there is some information
on N-acetyl aspartate and ascorbate (36,37). In general, these are bidirectional leak pathways with net solute movement depending on concentration gradient direction. Remarkably, organic osmolyte pathways commonly exhibit a pharmacologic profile similar to that
of the VSCC, suggestive of a common pathway with Cl– or of a close connection between
the two pathways (21,35). Other amino acids also responsive to swelling are glycine,
GABA, glutamate, and aspartate, which contribute to correction of osmotic disturbance
(38). However, this may create additional risks of excitability imbalance, due to their prominent role as synaptic transmitters, to be discussed later. There is recent evidence on
hyposmolarity-induced glutamate release insensitive to Cl– channel blockers, at clear variance with other organic osmolytes (39). This is suggestive of either different pathways or
different stimuli and mechanisms for release of this particular amino acid.
Volume Sensor and Osmotransductive Signaling
How cells sense volume changes is the initial and critical step in the chain of reactions
activated for volume correction, yet this has remained elusive to date. Among possible
mechanisms considered to play this role are membrane receptors such as integrins or receptors with intrinsic tyrosine kinase activity, cytoskeleton rearrangements, dilution of cytosolic macromolecules, decrease in intracellular ionic strength, stretch-induced activation
of adhesion molecules, activation of phospholipases, or changes in the concentration of
signaling molecules such as Ca2+ or magnesium (Mg2+) (fig. 2). Although to date none of
these possesses sufficient supporting experimental evidence, this is at present a very active
field of research (40). The question of volume sensing is also closely related to mechanisms
of osmolyte flux inactivation. At present, this is an essentially unexplored aspect of RVD.
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Figure 2. Hypothetical scheme of the elements of volume sensing, osmotransduction, and
activation of osmolyte pathways. The volume sensor system includes membrane and submembrane elements such as integrins, membrane receptors with intrinsic tyrosine kinase
activity (TKR), annexins, and cortical actin cytoskeleton remodeling. Osmotransduction
signaling includes Ca2+ and a number of protein tyrosine kinases, including focal adhesion
kinase (FAK), SYK, src-related kinases (srck), the tyrosine-kinase-activated kinase phosphoinositide-3 kinase (PI3K), and protein kinase C (PKC). The small GTPase Rho and its
kinase RhoK may also act as osmosignaling elements. Not all enzymes appear involved
in the same cell type.

Calcium and protein kinases are among the most likely candidates to act as osmotransductory elements. One of the most constant features of hyposmotic swelling is an increase
in cystolic Ca2+ (32) (fig. 2). Despite this, the main corrective osmolyte efflux pathways and
consequently RVD are Ca2+-independent in a large variety of cell types. This is the case for
brain cells, in which VSCC, VSKC, and organic efflux pathways are largely Ca2+-independent
(32). The more commonly accepted interpretation of these results is that cytosolic Ca2+ increase is an epiphenomenon resulting from activation by swelling of Ca2+ influx pathways
and/or of release mechanisms from intracellular stores (41), but that this increase is not
part of the osmosignaling cascades. In cells such as epithelial cells, the magnitude of hyposmolarity-evoked cytosolic Ca2+ elevation is sufficient to activate Ca2+-dependent large
conductance K+ channels, which once activated, predominantly contribute to RVD. As a
consequence, RVD is Ca2+-dependent in these cells (32).
Protein kinases of different types modulate some osmolyte pathways. In contrast to the
constancy of the cytosolic Ca2+ elevation, the effect of protein kinases appears to be cellspecific. Protein kinase C (PKC) appears involved in the function of the VSCC but with
different effects (activation or inhibition) according to cell type (22). Protein kinase A does
not influence RVD in most cells but may be involved in the modulatory action of hormones
and other factors on cell volume regulation. Protein tyrosine kinases (PTK) have recently
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received special attention as elements of the osmotransduction cascades as a result of the
potent effect of blockers of PTK reducing the osmosensitive efflux of Cl– and taurine
(42,43). This effect has been reported in cultured astrocytes and neurons and in more integrated preparations such as the supraoptic nucleus and hippocampal slices (34,39). In vivo,
PTK appear related to swelling-evoked amino acid release in heart Langendorff preparations (44). Furthermore, in cultured cells inhibition of tyrosine phosphatases, which prolong the protein phosphorylation reaction, increases osmolyte fluxes (42) (fig. 2). A
modulatory role of PTK on volume-sensitive K+ channels has not been reported but Ca2+
and PKC are involved in VSKC in some cell types, as previously mentioned (fig. 2).
The site within the complex signaling network modulated by PTK has not been identified. A possible target is the phosphoinositide kinase PI3K, a tyrosine-kinase-activated kinase, because inhibition of this enzyme has a marked influence in reducing the volumecorrective fluxes of Cl– and taurine (42,43). PI3K is a key element in signaling cascades with
links to tyrosine-kinase membrane receptors and the integrin-FAK pathway. PI3K also relates to small GTP-ases of the Rho family that in turn modulate the dynamics of the cytoskeleton (45) (fig. 2).
A role for phospholipases in osmotransduction, in particular the cPLA2 form, is suggested by reports in neuroblastoma and in Ehrlich ascites cells, showing a strong correlation between arachidonic acid release and volume-sensitive taurine efflux, which are
blunted by blockers of this specific enzyme (46).
Isovolumetric Regulation
The experimental model of abrupt and large reduction in external osmolarity has contributed importantly to our knowledge concerning the mechanisms by which cells face osmotic challenges. However, this model does not closely reproduce the conditions in vivo.
Even in acute hyponatremia, changes in external osmolarity never exceed –16% and onset
of hyposmolarity appears gradually. A better paradigm for approaching these conditions
was developed by Lohr and Grantham (47) in renal tubule cells exposed to small and gradual changes in osmolarity. Under these conditions, cells do not swell even if external osmolarity is drastically decreased. This constancy in cell volume is not due to swelling being
restricted, but is rather due to rapid and efficient correction of the continuous change in
water content. This volume adjustment, similar to models of abrupt hyposmotic shock,
appears to be accomplished by active extrusion of intracellular osmolytes (48). Molecules
involved and mechanisms in operation are not known in detail, as studies on isovolumetric
regulation (IVR) are still scarce. Occurrence of IVR has been found in only two types of
renal cells (47,49), in hippocampal slices (50) (fig. 3), and with lower efficiency in C6 glioma
cells (51) and in cardiomyocytes (52). In A6 cells and in myocytes, IVR stimulates K+ release, but only at delayed phase of IVR, with an efflux threshold at –30% hyposmotic external osmolarity. In contrast, amino acids, particularly taurine, appear involved at earlier
phases of volume regulation, showing efflux thresholds at approximately –10 to 12% hyposmolarity (50) (fig. 3). There is no information on osmotransduction factors or signaling
messengers involved in this model of volume regulation, and possible similarities or dissimilarities of this mechanism of volume control in different cell types have not been explored to date. This is an interesting avenue of research because as previously mentioned,
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this experimental model approaches physiologic and pathologic situations generating
changes in cell volume in brain.

Figure 3. Isovolumetric regulation in hippocampal slices. A. Slice water content remains
unchanged when slices are exposed to small and gradual changes in osmolarity (1.8
mosm/min). B. Constancy in cell volume is an active process accomplished by the efflux
of osmolytes, as illustrated for taurine efflux. Details of experiments are described according to Franco et al. (49).

Hyponatremia and Hyperexcitability
A serious clinical consequence of acute and severe hyponatremia is the generation of epileptiform activity and increased susceptibility to seizures (53). In studies in hippocampal
slices, osmolarity reduction causes an increase in amplitude of evoked field potentials and
of excitatory postsynaptic potentials, which is inversely related to osmolarity (54). Hyposmolarity does not affect cell properties such as resting membrane potential, cell input
resistance, and action potential threshold and duration (55). The manner in which osmolarity alters synaptic transmission is not fully understood. It may result from either hyperfunction of excitatory synapses and/or from nonsynaptic mechanisms derived from
reductions in the size of the extracellular space. The increase in excitatory synaptic activity
may be the consequence of the well-documented, swelling-activated glutamate release
(39,55). On the other hand, narrowing of the extracellular space due to cell swelling may
also be a source of hyperexcitability, either by enhancing ephaptic interactions and/or because increase of extracellular K+ concentration and reduced diffusion of neurotransmitters
prolong the synaptic function (53,56). These possibilities, which do not exclude each other,
may all contribute to generate hyposmotic-associated hyperexcitability. In support of this
interpretation, the Cl– channel blocker furosemide prevents extracellular space reduction
and blocks epileptiform activity in a variety of in vitro models (57). Furosemide prevents
the kainic acid-induced, synchronized burst discharges in hippocampal slices (57).
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Differences in Brain Cell Swelling in Hyponatremia
Cultured brain cells exposed to hyposmolarity reductions exhibit an immediate and general increase in cell swelling. However, this homogeneity has not been observed in more
integrated preparations, in which the response of individual neurons to lowering osmolarity varies greatly. In pyramidal cells freshly isolated from CA1 region of the hippocampus, at least three different populations of cells could be identified according to their
response to decreasing osmolarity. One group of cells swells immediately, while other
groups exhibit a delayed response or are resistant to swelling (19). Differences are also
observed between hippocampal regions in which CA1 and the dentate gyrus swell more
than CA3 (58). Within the same region, as in CA1, the stratum radiatum and the stratum
oriens containing the apical and basal dendrites, respectively, are notably more responsive
to hyposmotic swelling than the stratum pyramidale, formed by the cell somata (58). The
reason for these differences is unclear to date. Lack of swelling in some cells or regions
may result from (i) an intrinsic mechanism preventing water entry such as reduced expression of aquaporins, (ii) activation of highly efficient processes of volume adjustment, or
(iii) temporary redistribution of osmolytes to nearby cell compartments. In this respect, an
elegant in vivo study by Nagelhus and co-workers (59) in cerebellum of water-loaded rats
shows an immediate redistribution of taurine-cell content in Purkinje cells to nearby glial
elements in response to the hyposmotic condition. As a result, astrocytes swell while neurons are spared (fig. 4).
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Figure 4. Redistribution of taurine-like immunoreactivity in rat cerebellar cortex following water loading. Details of the experiment are as in Reference 58. Photomicrographs of
pairs of neighboring semi-thin sections treated with taurine antiserum are as described in
Reference 58. Animals were treated with isotonic saline (A) or water (B) 4 h prior to killing, or with water followed by hypertonic saline (C). The figure shows the highly concentrated taurine in Purkinje cells (large arrows), which upon water load is transferred to the
adjacent glial elements (arrows). The original distribution is restored after hyposmolarity
correction. Double arrowheads represent different types of cells labeled with taurine. This
is part of figure 2 from the work by Nagelhus et al. (58), reproduced with permission.
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Risks of Rapid Correction of Hyponatremia
Acute, severe hyponatremia (Na+ serum concentration <115 mM) produces clear symptoms of neurologic damage due to brain edema, with the consequent increase in intracranial pressure. The commonly used procedure to correct hyponatremia is administration of
hypertonic saline solutions. Saline/acetate solutions have also proved highly efficient to
correct mild hyponatremia (60). In cases of SIADH, fluid restriction is usually the first line
of treatment. It is important to mention in this respect that a clear distinction should be
made between a diagnosis of SIADH and of CSWS, which as mentioned previously may
have similar symptoms. While fluid restriction is appropriate to correct hyponatremia associated with SIADH, it is detrimental to patients with CSWS and can even be lethal (2,61).
An increase in plasma Na+ concentration of approximately 10–15 mmol/L is normally sufficient to prevent permanent brain damage in severe, acute hyponatremia. It is currently
accepted that the rate of correction of acute hyponatremia should be no more than 0.5
mmol/L/h and should be interrupted when serum Na+ levels have increased to 125–130
mmol/L (62). These precautions are necessary because overly excessive and rapid corrective procedures may result in brain injury, likely due to the adaptive mechanisms developed to counteract hyponatremia described in this review. As a consequence of these
adjustments, solute intracellular pools change their concentration to attain an osmotic balance with the external modified condition, i.e., the osmolarity of the cytosol is in equilibrium with an external hyposmotic environment. When the increase in plasma tonicity that
accompanies correction of chronic hyponatremia restores the normal isosmotic condition,
this condition is now sensed as hyperosmotic by brain cells, which consequently dehydrate
until new adaptive mechanisms are activated. The main risk of this situation is a neurologic
sequel of demyelinating lesions in the brain, a pathology known as osmotic demyelination
syndrome (8). This pathologic entity is characterized by a symmetric focus prominently in
the basis pontis, but extrapontine demyelinating lesions have also been found in the basal
ganglia, internal capsule, lateral geniculate body, and cortex (63). The salient clinical features of the syndrome include motor abnormalities progressing to flaccid quadriplegia,
occasional respiratory paralysis, mental state disturbances, lethargy, and coma. Why demyelination develops is not well understood. Recent studies have focused on a disruption
of the brain blood barrier as the gating factor of the degenerative process (64,65). The current hypothesis is that disruption of the tight junctions of the blood brain barrier as a consequence of brain dehydration might expose oligodendrocytes to substances normally
excluded from the brain, such as complement, which could be the precipitous factor of
demyelination. Situations predisposing to the development of the demyelination syndrome associate with preexisting conditions such as alcoholism and malnutrition (8). Particular care should be taken in correcting hyponatremia in patients with an associated
clinical condition of hypoxia. Studies in animals as well as in humans (66–68) have shown
that hypoxia combined with hyponatremia produces a major increase in brain edema, injury, and mortality. This is possibly a consequence of inefficiency of the compensatory
mechanisms of cell volume regulation due to intracellular Na+ increase and subsequent Cl–
influx occurring in the hypoxic condition as a result of the energetic failure (69).
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Conclusions
Knowledge concerning the cellular and molecular mechanisms subserving brain adaptation to hyponatremia has notably progressed in the last decade. All of this information has
contributed to understanding the risk of the pathologic consequences of an inappropriate
correction of the hyponatremic patient and to guide the clinicians toward a rational, optimal therapeutic approach.
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